CASE STUDY: VERSAFLEX™ OM TPES THE CHALLENGE Millions of people of all ages play video games. The company needed to find the right material that met all their requirements to create the new control grips. According to the company, the precise thumb control and long-term comfort has made these new accessories “wildly popular.” 1 http://www.statista.com/statistics/237749/value-of-the-global- entertainment-and-media-market/ AVIENT HELPS GAMING ACCESSORIES COMPANY TAKE AIM AT NEW OPPORTUNITIES © 2020, All Rights Reserved Avient Corporation, 33587 Walker Road, Avon Lake, Ohio USA 44012 To learn more, please contact Avient at +1.844.4AVIENT (1.844.428.4368)

You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product. It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device with all applicable laws and regulations, including the suitability of all raw materials and components used for its manufacture.

You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product. It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device with all applicable laws and regulations, including the suitability of all raw materials and components used for its manufacture.

You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product. It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device with all applicable laws and regulations, including the suitability of all raw materials and components used for its manufacture.

In addition to all of these challenges, the local masterbatch supplier couldn’t provide the proper documents to certify the materials met Reduction of Hazardous Substances (RoHS) and Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) requirements. With RoHS and REACH documentation on all masterbatch orders, international customers were an option once again. COLLABORATION HELPS FLUOROPOLYMER CABLE MANUFACTURER WIN BUSINESS, CUT COSTS © 2020, All Rights Reserved Avient Corporation, 33587 Walker Road, Avon Lake, Ohio USA 44012

All our solutions for stadium and arena seats are compliant under REACH and RoHS. UV STABILIZER/COLOR COMBINATIONS • Combines color and UV stabilization for use in PP and PA • Ingredients screened with accelerated weather testing* • Excellent weather resistance properties (against chalking, embrittlement) • Long-term colorfastness and light stability UV STABILIZER/FLAME RETARDANT/ COLOR COMBINATIONS • Combines low halogen flame retardants, UV stabilizers and color for use in PP and PA • Ingredients screened with accelerated weather testing* • Excellent weather resistance properties (against chalking, embrittlement) • Compliant with local fire standards (e.g.: AFNOR M 2 in France, DIN 4102 B 2 – B 1 in Germany, UNI 8457 – 9174 C 1 in Italy, BKZ 5.2 in Switzerland, BS 5852.1990 CRIB 3-5 in UK)** • Standard portfolio available for PP injection molded applications APPLICATION BULLETIN * Laboratory weathering testing may not be determinative of all conditions of use; the end user must determine suitability of a product for its intended use ** Contact us for more information on regulatory compliance Copyright © 2022, Avient Corporation. You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product.

Your colors can be consistently reproduced from any Avient facility worldwide. 1 2 VISIT ONE OF OUR SELECT FACILITIES Alternatively, you can visit one of our global Select development facilities and work with one of our experts to create your color, produce and approve samples all in the same day. With instant online access, colors can be evaluated and managed with the full assurance that they can be reproduced consistently, with all the necessary approvals, anywhere in the world, at any time. You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product.

General Purposes The general purposes of the Committee are to: • Develop the Company’s overall executive compensation philosophy and objectives; • Discharge the Board’s responsibilities relating to compensation of the Company’s executive officers and, further, to assist the Board in the discharge of its fiduciary responsibilities with regard to establishment of policies governing, and the implementation of, all aspects of remuneration throughout the Company, including benefits and perquisites of executive officers of the Company and any other employees designated by the Committee as key employees of the Company and its subsidiaries; • Discharge similar responsibilities with respect to the remuneration of non-employee directors; • Review and discuss with management the Company’s disclosures in the Compensation Discussion and Analysis (the “CD&A”) required by rules and regulations of the Securities and Exchange Commission (the “SEC”) and recommend to the Board whether the CD&A should be included in the Company’s proxy statement or other applicable SEC filings; • Prepare a Compensation Committee Report for inclusion in the Company’s applicable filings with the SEC that complies with the rules and regulations of the SEC; and • Provide policy guidance and oversight on significant human resource policies and practices. Independence Assessment of Outside Advisers • The Committee may select a compensation consultant, legal counsel or other adviser to the Committee or receive advice from a compensation consultant, legal counsel or other adviser (other than in-house legal counsel or any compensation consultant, legal counsel or other adviser whose role is limited to the following activities for which no disclosure would be required under Item 407(e)(3)(iii) of Regulation S-K: consulting on any broad-based plan that does not discriminate in scope, terms, or operation, in favor of executive officers or directors of the Company, and that is available generally to all salaried employees; or providing information that either is not customized for a particular company or that is customized based on parameters that are not developed by the compensation consultant, and about which the compensation consultant does not provide advice) only after taking into consideration all factors relevant to that person’s independence from management, including the following: • the provision of other services to the Company by the employer of the compensation consultant, legal counsel or other adviser; 5 • the amount of fees received from the Company by the employer of the compensation consultant, legal counsel or other adviser, as a percentage of the total revenue of the employer of the compensation consultant, legal counsel or other adviser; • the policies and procedures of the employer of the compensation consultant, legal counsel or other adviser that are designed to prevent conflicts of interest; • any business or personal relationship of the compensation consultant, legal counsel or other adviser with a member of the Committee; • any stock of the Company owned by the compensation consultant, legal counsel or other adviser; and • any business or personal relationship of the compensation consultant, legal counsel, other adviser or the employer of the adviser with an executive officer of the Company. • The Committee shall evaluate whether any compensation consultant retained or to be retained by it has any conflict of interest in accordance with Item 407(e)(3)(iv) of Regulation S-K. However, the Committee shall meet regularly without such members present, and in all cases the Chief Executive Officer and any other such officers shall not be present at meetings at which their individual compensation or performance is discussed or determined. • The Committee may appoint subcommittees from time to time as needed, each of which will have the specific duties and responsibilities delegated to it by the Committee. • The Committee may delegate its authority under this Charter relating to employees other than executive officers and non-employee directors, to the extent it deems appropriate and consistent with law and customary practice, and may otherwise fully delegate authority relating to matters it deems to be ministerial. • The Committee may delegate its authority under this Charter relating to employee benefit plans in which executive officers participate if such employee benefit plans are broad-based, to the extent it deems appropriate and consistent with law and customary practice. • The Corporate Secretary or designee will be responsible for keeping minutes of the Committee meetings. • The Committee will meet at least four times a year and at such other times as may be requested by the Committee Chair. • The Committee will annually review its charter and recommend any changes to the Nominating and Governance Committee.

All nominees should be individuals of substantial accomplishment with demonstrated leadership capabilities. All such actions, interpretations and determinations that are done or made by the Board in good faith will be final, conclusive and binding. 2. Directors should regularly attend meetings of the Board and of all Board committees on which they serve.

MEDICAL CONTRACT MANUFACTURER A U T O - I N J E C T O R H O U S I N G • Excellent chemical and wear resistance • Excellent impact resistance • Specific color matching based on customer’s needs • Outstanding durability to extend product life • Customized a chemically resistant formulation to offer an impact-modified alternative to traditional competitors in the market • Provided technical support for material selection, part & tool design, and process development to accelerate commercialization • Delivered custom color matching to meet all key requirements Custom Trilliant™ HC Healthcare Thermoplastic KEY REQUIREMENTS WHY AVIENT? All Rights Reserved. https://www.avient.com/products/engineered-polymer-formulations/chemical-corrosion-resistant-formulations/trilliant-hc-healthcare-thermoplastics